Ascendis Pharma A/S Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-12-30: Form 6-K; Period of report 2024-12-30; Description 6-K; Document d905429d6k.htm.
- 2024-12-17: Form 6-K; Period of report 2024-12-17; Description 6-K; Document d918920d6k.htm.
- 2024-12-12: Form 6-K; Period of report 2024-12-12; Description 6-K; Document d862935d6k.htm.
- 2024-12-11: Form 6-K; Period of report 2024-12-11; Description 6-K; Document d880948d6k.htm.